Previous 10 | Next 10 |
Wall Street Firms Are Bullish On These 5 Cheap Stocks Finding cheap stocks to buy doesn’t have to be complicated. Discovering new trends and opportunities early. Just look at the surging stocks this week like Virpax Pharma ( NASDAQ: VRPX ) and SGOCO Group, Ltd. ( ...
BUFFALO, N.Y., Aug. 17, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII ), a leading plant-based biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and hemp/cannabis research, today announced that its Chief Executive Officer, James A. ...
BUFFALO, N.Y., Aug. 16, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII ) (formerly NYSE American: XXII), a leading plant-based, biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and hemp/cannabis research, announced today that it wil...
LOS ANGELES, CA / ACCESSWIRE / August 16, 2021 / The SNN Network Summer Virtual Event will take place on August 17-19, 2021, where 60 SmallCap, MicroCap and NanoCap public and private companies will be presenting via virtual webcast to a global investor audience. The SNN Network Summer Virt...
Image source: The Motley Fool. 22nd Century Group (NYSEMKT: XXII) Q2 2021 Earnings Call Aug 05, 2021 , 10:00 a.m. ET Operator Continue reading For further details see: 22nd Century Group (XXII) Q2 2021 Earnings Call Transcript
Investors are familiar with the headline names in the cannabis industry , but the very fact they're so well known indicates they may be trading at valuations that reflect the attention they've received. For those wanting to catch the green wave ahead of the rest of the market, looki...
BUFFALO, N.Y., Aug. 05, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII ), a leading plant-based, biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and hemp/cannabis research, announced today that its common stock has been approved...
22nd Century Group, Inc. (XXII) Q2 2021 Results Conference Call August 05, 2021 10:00 AM ET Company Participants Mei Kuo - Director of Communications and Investor Relations Jim Mish - Chief Executive Officer Mike Zercher - President and Chief Operating Officer John Franzino - Chief Financial ...
22nd Century (NYSE:XXII): Q2 GAAP EPS of -$0.03 in-line. Revenue of $8.4M (+31.3% Y/Y) beats by $1.32M. Gross profit for the second quarter of 2021 improved by $385 thousand, or 192% to $586 thousand compared to the prior year period. The Company ended the quarter with a cash position of $62....
Initiated International Launch Process For VLN ® , First Sales Planned by First Quarter 2022 First Revenue From Hemp/Cannabis Franchise to Commence in Second Half of 2021 Third Plant-Based Franchise to be Introduced on August 30, 2021 Uplisting common shares to the Na...
News, Short Squeeze, Breakout and More Instantly...
22nd Century Group Inc Company Name:
XXII Stock Symbol:
NYSE Market:
22nd Century Group Inc Website:
Patented, Fully Water Dispersing, Biodegradable Solution for World's Most Littered Item Mocksville, North Carolina--(Newsfile Corp. - July 10, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction and contract manufacturing, today announce...
Mocksville, North Carolina--(Newsfile Corp. - July 9, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction and contract manufacturing, today announced a new agreement for full-scale commercial rollout of its VLN® reduced nicotine cont...
Mocksville, North Carolina--(Newsfile Corp. - June 25, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction and contract manufacturing, today announced a $1.5 million reduction in its secured debt via a paydown of the GVB secured promissor...